Researchers at the University of California San Diego have completed a massive genetic study that identifies key biological drivers of cocaine addiction, uncovering a potential new target for treatment that resides in the liver rather than the brain.

How this affects you

This genetic study identifies a liver-based enzyme as a potential target for treating cocaine addiction, suggesting that altering how the body metabolizes cocaine could reduce its addictive impact. This could lead to new therapies and diagnostic tools for individuals struggling with substance use disorders.